Drug Recall for K-Citra 10 Tablets

HPS Pharmacies wish to give notice that Lacuna Pharma, in consultation with the Therapeutic Goods Administration (TGA), has initiated a drug recall for K-Citra 10 tablets as follows:

K-Citra 10 Tablets
Potassium Citrate 1080mg
ARTG 405527

The batches affected by this drug recall are:

• 42301133-B (Exp: 02/2026)
• 42204121-B (Exp: 02/2026)

This drug recall was initiated due to a typographical error on the product label of the two batches mentioned above. The product label contains the incorrect strengths of 629.4 mg for the Potassium component and 390.6 mg for the Citrate.

The correct concentration of Equivalent Potassium is 390.6 mg, and the correct concentration of Equivalent Citrate is 629.4 mg.

Please inspect your stock and quarantine all affected products. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier, and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Lacuna Pharma on (02) 4339 4239 or your pharmacist at HPS Pharmacies.

Download PDF